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Abstract
Introduction and Aims. Personal vaporisers (PV), including e-cigarettes, may be a harm reduction strategy for tobacco
control. This study aims to identify factors associated with future intentions to vape among smokers and ex-smokers in Australia
and the UK. Design and Methods. Cross-sectional data of smokers and ex-smokers (n = 1199, mean age = 45.3 years,
44.8% male), collected in 2014/2015 and divided into four subgroups: smoking past vapers (SPV), smoking vapers (SV),
ex-smoking past vapers (ESPV) and ex-smoking vapers (ESV), from the International Tobacco Control Australia and UK
surveys were analysed by using regression models. Results. Higher vaping satisfaction increased vaping intentions for all groups
except ESPV. Perceiving PVs as less harmful predicted intentions to vape for all groups except ESV. The importance of PVs for
stopping smoking predicted lower intentions to continue vaping for SV, but higher intentions to initiate vaping for SPV. The
importance of PVs for cutting down smoking was a positive predictor only for SPV. Among ex-smokers, importance for maintaining
not smoking was a positive predictor for ESPV, but not for ESV. The importance of perceiving vapour being less harmful also
depended on vaping status for ex-smokers. The only country interaction was that only in the UKwas perceiving PVs as less harmful
associated with intention among SPV. Discussion and Conclusion. Factors inﬂuencing intentions vary by smoking and/or
vaping status, with greater differences between the ex-smoker subgroups. This is consistent with PVs being seen as a way of managing
smoking, rather than something that has intrinsic value, for all except the ex-smoking vapers. [Ma BH, Yong H-H, Borland R,
McNeill A, Hitchman SC. Factors associated with future intentions to use personal vaporisers among those with some
experience of vaping. Drug Alcohol Rev 2017;00:000–000]
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Introduction
Personal vaporisers (PV), also known as e-cigarettes, are
relatively new products that have generated huge
controversy. Some argue that they may play a central role
in speeding the elimination of smoking [1,2]; others are
concerned that they may appeal to many non-smokers
who would not otherwise use nicotine or, in the case of
ex-smokers, return to smoking [3]. This paper is
concerned with factors that might motivate smokers and
ex-smokers who are either: (i) past vapers (with some
experience of use) to take vaping up; or (ii) current vapers
to continue vaping. The paper is restricted to two
countries, Australia and the UK, which have markedly
different regulatory environments around these products.
Awareness and use of PVs is growing internationally,
with the levels of use in each country apparently
inﬂuenced by the prevailing societal response towards
them [4]. In Australia, there is no speciﬁc nation-wide
law addressing the regulation of PVs. Instead, laws
relating to therapeutic goods, poisons and tobacco
control apply to PVs under different circumstances.
Vaping with nicotine is prohibited except with a doctor’s
prescription. By contrast, UK has welcomed a harm
reduction framework. Under the European Union
Tobacco Products Directive [5] implemented in May
2016, England has moved towards regulating PVs largely
as consumer products with limits on levels of nicotine.
Limited advertising is allowed, largely local, such as at
point of sale, and sales to under 18-year-olds are
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prohibited [6]. Based on the International Tobacco
Control (ITC) survey, current use of PVs in Australia
increased from 0.6% in 2010 to 6.6% in 2013. By
contrast, in the UK, current use rose from 4.5% to
18.8% respectively [4]. More recent data from the UK
showed prevalence of use increased further from 16.8%
in early 2013 to 21.6% in early 2016 [7].
People evaluate whether to perform a behaviour
based on both the instrumental and experiential
components of the given behaviour [8,9]. Research has
identiﬁed ﬁve major instrumental reasons for vaping:
ﬁrst, to help quit smoking or avoid relapse [10–20]
and second, to deal with cravings and withdrawal
symptoms [10,11]. One study found that 90% of vapers
reported that it provided relief from cravings [10].
Third, they are perceived to be less harmful than
ordinary cigarettes [10–13,15,16,21,22]. One study
found that 70.3% of the respondents who were aware
of PVs perceived them to be less harmful than
traditional cigarettes [21]; however, this belief has
declined in some countries, such as UK [23]. Fourth,
some vape to reduce their cigarette consumption
[11,15,18,19,24]. Fifth, a small proportion choose PVs
because they are cheaper (realistic especially for the
reﬁllable tank types) [10,14]. The other major reason
to vape is experiential—the satisfaction they experience
from use (desired psychoactive effects), complemented
by more pleasant taste and smell [18].
There is little research relating reasons for use to
intentions to continue use or to future use. Social [25]
and temporal comparison [26] theories propose that
individuals tend to evaluate their attitudes by using
reference points, such as current behaviour or
expectancies from their social group. More generally,
Context, Executive, and Operational Systems theory [9]
proposes that behavioural choices are made through a
combination of beliefs about the value of the behaviour
for them and direct effects, especially affective reactions
to the behaviour, the latter being modulated by beliefs
about those reactions. Where the two sets of inﬂuences
are congruent, current behaviour patterns are likely to
be sustained, and if they shift in tandem, there will be a
rapid change in behaviour. This analysis is based on the
principle that we tend not to do things that we do not
perceive or experience any value for, and thus,
behaviours that persist must have value for the person, if
only the immediate affective experiences of use.
However, when there are conﬂictingmotivations, as there
are for smoking, attempts to change behaviour are likely
to fail.
Based on the analysis in the preceding texts, we predict
that interest in future use is likely to vary by smoking
status, with ex-smokers who do not currently vape being
unlikely to be interested in use, except to prevent relapse.
Current non-vaping smokers are predicted to compare
vaping to smoking when deciding if they will vape in the
future. Similarly for current users, smokers are likely to
compare vaping to smoking in deciding whether to
continue vaping. Vaping is also predicted to have its
potential as a quitting aid, or at least a means of limiting
smoking consumption, being strongly associated with
continued use. Vaping ex-smokers are predicted to want
to continue if they value the experiences of use or to
sustain abstinence from smoking. Finally, we also
examined if the different policy environments in
Australia and the UK would impact on both types of
intention by testing for any by country interactions.
Methods
ITC study design
Data come from one wave of the Australian andUK arms
of the ITC Four Country (ITC-4) survey. The ITC-4
study is conducted via a mix of telephone and web-based
methods. Data were collected between September 2014
and February 2015. The longitudinal study recruits
smokers aged 18 years and older, but retains those who
subsequently quit. The initial sample and replenished
samples up to 2012 were recruited by using the random
digital dialling method, and some of the new participants
from the latter waves (2013 and 2014 surveys) were
recruited by phone from a single source probability-based
panel via an address-based frame. Detailed descriptions
of the ITC-4 conceptual framework [27] and methods
[28] are available elsewhere.
Participants
From 2941 surveyed, 1199 participants who had ever
tried using PVs were included in this study. They were
divided into four subgroups based on smoking and
vaping status: 480 smoking vapers (SV), 549 smoking
past vapers (SPV), 88 ex-smoking vapers (ESV) and 82
ex-smoking past vapers (ESPV). Current vapers were
deﬁned as those who currently use an e-cigarette at all,
even as low as less than weekly.
Measures
The questions we asked used ‘e-cigarette’ as the generic
descriptor (as we believed it was the most used term at
the time), but it was deﬁned ﬁrst and speciﬁed that it
included e-shisha and PVs.
Outcomes
Intentions to use PVs in future/continue to use. For current
vapers, future intention to use was assessed by using the
B. H. Ma et al.
© 2017 The Authors Drug and Alcohol Review published by John Wiley & Sons Australia, Ltd on behalf of Australasian Professional Society on Alcohol and other Drugs.
 Predictors of future intentions to vape 217
question ‘Do you plan to keep on using e-cigarettes, or do
you plan to stop using sometime in the foreseeable
future?’, with a binary response of ‘(1) keep using’ versus
‘(0) plan to stop sometime in the foreseeable future’; for
past vapers, intention was assessed by using the question
‘Assuming that you have the opportunity, how likely are
you to use e-cigarettes in the future?’, with a 5-point scale
response option ranging from ‘(5) deﬁnitely yes’ to ‘(1)
deﬁnitely not’. The wording of the questions was
designed to eliminate lack of availability as a possible
reason.
Predictors
Past experiences and belief about vaping. Four questions
(see Table S1 for actual wording) were used to assess
past experiences of vaping: level of satisfaction derived
from PVs relative to ordinary cigarettes [rated on a
5-point scale from (1) totally unsatisfying to (5)
more satisfying], negative side effects related to PV
use [(2) yes/(1) no], number of friends and family
using PVs daily [from (1) none to (4) four or more]
and use of PVs inside home [(2) yes/(1) no]. A single
question assessed perceived harmfulness of PVs relative
to regular cigarettes, rated on a 5-point scale from a lot
less to a lot more harmful, dichotomised into ‘(1) less
harmful’ versus ‘(0) no less harmful’ (including equal
and don’t know) for analysis.
Importance of reasons for using PVs in future/continue to
use. Twelve questions assessed the importance of both
experiential (Questions 6, 7 and 16 in Table S1) and
instrumental (Questions 8–15 and 17) reasons for
deciding to use PVs in the future, either continuing to
use or taking vaping up, rated on a 5-point scale from
(1) not at all important to (5) extremely important.
Questions about using PVs in smoke-free areas, for
stopping smoking and for cutting down smoking were
asked only of smokers (Questions 10–12), while those
about using PVs as a way of not smoking and to stop from
returning to smoking were asked only of ex-smokers
(Questions 13–14).
Based on correlations, two pairs of variables, ‘safety’
and ‘less harmful’ (r = 0.67, see Table S1), and ‘not
returning to smoking’ and ‘not smoking’, were
combined by averaging their scores to yield ‘less
harmful’ (Table 2) and ‘help to stay quit or prevent
relapse’ (Table 4). The importance of stopping
smoking and cutting down smoking were also very
highly correlated (r = 0.86), but were not combined
on theoretical grounds: Cutting down is more likely
to imply persisting dual use if it predicts differentially
to stopping.
Control variables
Age, sex, country, cohort, survey mode (phone vs.
Internet), ever daily use of PVs, heaviness of smoking
index (for smokers) and quit attempts in the last 6months
(for smokers).
Data analyses
All analyses used STATA 14. Group differences were
examined by using analysis of variance for continuous
variables and χ2 tests for categorical ones. In the main
analysis, the four subgroups were analysed separately.
Logistic regression models were employed to predict
intention to keep using in SV andESV, a binary outcome,
while linear regression models were used to predict
intention to use (a continuous outcome measure) in
SPV and ESPV. Bivariate regression analyses were
initially performed on each of the set of key questions,
followed by multivariate analyses that adjusted for
potential confounders (control variables) (M1) to
examine motives independently associated with the
intention to use, and intention to keep using, PVs in the
future. These were then followed by backward stepwise
regression analyses (M2) to identify the most signiﬁcant
independent associates of intention to use and intention
to keep using PVs, but only including those with a P-
value for effect of less than 0.3 in order to reduce the
number of variables in the stepwise regressions. In
addition, due to the relatively small sample of ex-
smokers, the control variables that were included were
those with a P < 0.3 level of association with the
outcome.
Results
Detailed characteristics are presented in Table 1. The
four subgroups differed by education, income, country
and survey mode. Among vapers, smokers were more
likely to intend to continue PV use than ex-smokers.
Similarly, among past vapers (only 34% with daily
experience; >1 week), smokers were even more
interested in PV use than ex-smokers. It is notable that
in the two past-vaper groups, only a small minority
expressed any intention to vape again, and among the
vapers, only aminority were interested in continuing, less
among the ex-smokers.
There were large by-group differences in possible
motives (Table 2). As might be expected, past vapers
had generally lower scores on both the experience
and importance measures than vapers. Among vapers,
the ex-smoker group generally had more positive
attitudes and placed greater importance in the various
reasons than the current smokers. Among past vapers,
Predictors of future intentions to vape
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there were few differences between the two smoker
groups. The only clear exception was that the
importance of satisfaction with vaping was higher in
smoking past vapers than ex-smoking past vapers.
This contrasts with the ﬁnding for vapers where
ex-smokers were more likely to endorse it than the
smokers.
Predicting intention to keep using PVs among SVs
Predictors of intention to continue vaping among SV
are presented in Table 3. Higher level of satisfaction
with vaping was positively related to intention to
continue using PVs in all analyses, with the effect
remaining strong in the combined model, as was
perceiving PVs to be less harmful than conventional
cigarettes and the importance of being able to use
PVs in smoke-free areas. By contrast, the importance
of using PVs to stop smoking was negatively associated
with continuing to use in the future.
Predicting intention to use PVs among SPVs
There were more independent predictors of intention to
vape for SPV than SV (Table 3). Similar to SV, both
higher vaping satisfaction and perceiving PVs to be less
harmful were positively related to intention to use in the
future. Having experienced any side effects of PV use in
the past was associated with no future intention to use
PVs. Having friends or family members using PVs was
associated with increased interest in future use, as was
the importance of PVs being satisfying. Unlike for SV,
for SPV, the importance of using PVs to stop smoking
and to cut down smoking was positively related to
intention to use in the future.
Predicting intention to keep using PVs among ESVs
Table 4 shows that none of the past experience and belief
measures predicted intention to continue using PVs for
ESV. However, the importance of satisfaction with
vaping was positively related, while the importance of
Table 1. Characteristics of respondents who have ever used personal vaporisers by smoking and/or vaping subgroups
Variables SV (n = 480) SPV (n = 549) ESV (n = 88) ESPV (n = 82)
Country (%)*
Australia 31.3 45.5 15.9 47.6
UK 68.8 54.5 84.1 52.4
Age in years
Mean (SD) 45.0 (12.9) 45.2 (13.5) 45.6 (11.3) 44.6 (13.2)
Gender (%)
Male 45.0 44.4 50.0 40.2
Female 55.0 55.6 50.0 59.8
Education (%)*
Low 37.3 36.8 40.9 36.6
Medium 29.2 27.7 28.4 30.5
High 26.7 21.3 26.1 23.2
No information 6.5 14.2 4.6 9.8
Income (%)*
Low 48.5 44.6 43.2 24.4
Medium 22.7 24.6 27.3 30.5
High 21.9 21.7 21.6 29.3
No information 6.9 9.1 7.8 15.9
Survey mode (%)*
Web 76.7 62.1 70.5 84.2
Phone 23.3 37.9 29.5 15.8
Intention to continue to vape (%)*
Yes 39.2 NA 27.3 NA
No 60.8 NA 72.7 NA
Intention to take up vaping (%)*
Deﬁnitely yes NA 7.7 NA 1.2
Probably yes NA 16.9 NA 1.2
Might or might not NA 27.7 NA 13.4
Probably not NA 21.7 NA 28.1
Deﬁnitely not NA 26.0 NA 56.1
*Signiﬁcant subgroup differences at P < 0.05; ESPV, ex-smoking past vapers; ESV, ex-smoking vapers; NA, not applicable; SPV,
smoking past vapers; SV, smoking vapers.
B. H. Ma et al.
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how much less harmful second-hand vapour is was
associated with lesser intentions to continue.
Predicting intention to use PVs among ESPVs
Table 4 shows that perceiving vaping to be less harmful
was positively associated with intention to vape in future
for ESPV as were the importance of friends using and
the importance of PV use to help remain a non-smoker.
By contrast, the importance of how much less harmful
second-hand vaping is was negatively associated.
Country interactions
The only signiﬁcant by-country interaction was for
perceiving PVs to be less harmful than smoking in the
SPV group (P < 0.001). We repeated our analyses for
the SPV group stratiﬁed by country (Table S2). This
showed that the overall signiﬁcant effect of relatively
lower perceived harm of PVs as an inﬂuence on future
intentions occurred only in the UK with no association
for Australia.
Discussion
The results of this study showed that there is limited
interest in taking up vaping again among past users, and
most current vapers plan to stop using. The factors
potentially inﬂuencing future use of PVs varied by both
smoking and vaping status, but not always in the ways
we expected. None of the measures were consistently
associated with intentions in all four groups, but
importance of help to stop smoking was strongly related
for both smoker groups.
For smokers currently vaping, higher experienced
satisfaction with vaping and perceiving PVs to be less
harmful than conventional cigarettes were positive
predictors of intentions. This is consistent with previous
ﬁndings that vapers were more likely to believe PVs to
be less harmful than conventional cigarettes as compared
with past vapers [29]. Further, the more important they
think stopping smoking as a reason for using PVs is, the
less likely they plan to continue using PVs in the future.
This suggests that those who value the use of PVs to quit
smoking generally see their use as temporary, while the
minority who intend to continue to vape may be less
concerned about smoking cessation. The ﬁnding of a
positive relationship between perceived satisfaction with
vaping and intention to continue use suggests that as
PVs become engineered to better deliver nicotine [30],
interest in continued use may rise.
For smokers not currently vaping, past experiences
predicted future intentions. As expected, greater
satisfaction with vaping, perceiving them to be less
harmful than smoking, the importance of vaping
satisfaction and of their role in quitting and cutting down
were all associated with intentions to vape again. Taken
together, the ﬁndings also suggest that use is more likely
if they are shown to be superior cessation aids and are
mademore generally satisfying [10]. The only by-country
interaction for this group was of the belief that PVs are
Table 2. Means (SD) and percentages of predictor variables by smoking and/or vaping subgroups
Variables SV (n = 480) SPV (n = 549) ESV (n = 88) ESPV (n = 82)
Group difference
(overall P-value)
Past experiences and belief about PVs
Level of satisfaction 2.51 (0.89) 2.13 (0.83) 3.20 (1.05) 2.22 (0.86) a, b, c, d, f (<0.001)
Side effect (% yes) 11.9 10.2 9.1 8.5 (0.689)
Friends and family using 2.19 (1.03) 1.83 (0.97) 2.63 (1.15) 1.51 (0.92) a, b, c, d, f (<0.001)
Use at home (%) 67.5 NA 84.1 NA b (0.002)
Perceived less harmful (%) 72.1 60.7 85.2 58.5 a, b, c (<0.001)
Importance of reason for deciding to use
Satisfying 3.28 (1.10) 3.27 (1.34) 3.53 (1.12) 2.51 (1.33) b, c, e, f (<0.001)
Less smelly 3.24 (1.28) 2.75 (1.37) 3.57 (1.44) 2.90 (1.38) a, b, c, d, f (<0.001)
Friends using 1.79 (1.12) 1.40 (0.87) 1.58 (1.03) 1.51 (0.92) a, c (<0.001)
Manage stress 3.13 (1.26) 2.91 (1.39) 2.95 (1.28) 2.22 (1.19) a, c, e, f (<0.001)
Less harmful 3.59 (1.10) 3.41 (1.26) 4.16 (0.98) 3.12 (1.43) a, b, c, d, f (<0.001)
Relative harm of second-hand vaping 3.54 (1.20) 3.23 (1.31) 3.76 (1.14) 3.09 (1.27) a, c, d, f (<0.001)
Use in smoke-free area 2.89 (1.38) 2.45 (1.36) NA NA a (<0.001)
Help to stop smoking 3.51 (1.24) 3.28 (1.40) NA NA a (0.005)
Help to cut down smoking 3.56 (1.19) 3.21 (1.34) NA NA a (<0.001)
Help to stay quit NA NA 4.26 (1.07) 2.72 (1.46) f (<0.001)
ESPV, ex-smokers not currently vaping; ESV, ex-smokers currently vaping; NA, not applicable; SPV, smokers not currently vaping;
SV, smokers currently vaping. Statistically signiﬁcant group comparison: a = 1 versus 2; b = 1 versus 3; c = 1 versus 4; d = 2 versus
3; e = 2 versus 4; f = 3 versus 4.
Predictors of future intentions to vape
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less harmful, being positively associated with intentions
in the UK, but not in Australia. There is no ready
explanation for this country difference. However, if it is
real, it may be that the issues of access and greater
uncertainty about harm in Australia might have masked
the importance of risk perception as a determinant of
intention to use PV.
For ex-smokers currently vaping, experienced
satisfaction with vaping relative to smoking was not
related to intentions, while the importance of satisfaction
with vaping itself was. This suggests that once people
have given up smoking and taken up vaping, the
comparative experienced satisfaction of the two
behaviours is no longer important and what determines
future intentions to continue the current behaviour is its
intrinsic value. Interestingly, the importance of PV
vapour being less harmful to people around them was
negatively related to intention. It may be that this reﬂects
making comparisons between vaping and not using any
nicotine product at all (rather than with smoking), so if
they perceived vaping as having any level of harm, then
it would discourage continued use. It seems unlikely to
us that believing second-hand vaping to be relatively
harmless would inhibit use.
Turning now to ex-smokers not currently vaping,
believing PVs to be less harmful than ordinary cigarettes
predicted future intention as did several of the
importance measures. The latter includes friends using
and help to stay quit, both positively associated, while
relative harms of second-hand vapour to others were
negatively related as they were for ex-smoking vapers.
This latter ﬁnding strengthens our argument that this
question is being interpreted as concern that there might
be harm from exposure to second-hand vapour, not
literally as a response to ‘How much less harmful the
vapour is to others around you’. Taken together, it
suggests that concerns about harm to others from
second-hand exposure may be inhibiting some who
might otherwise use, but more may be willing to take it
up if it is seen as helpful for staying quit.
This study has several limitations. First, we use
country as a proxy for the different policy environments,
and by-country differences could be caused by many
other factors. However, as we only found one interaction,
suggesting that neither is particularly important. This
means that we can more conﬁdently generalise our
ﬁndings to comparable countries and a wide range of
policy environments. Second, our study relies on
cross-sectional comparisons that are usual in studies of
intention. Intention is logically the consequence of past
experiences, but it can affect how a person recalls and
describes their past experiences, so we cannot rule out
the possibility that the intentions, once formed, reshaped
reported beliefs and reasons for intending. Further, we
did not study those with no experience of vaping who
may be less likely to intend to use than those with past
experience. Another limitation is the relatively small
sample size for ex-smokers and the smaller samples of
vapers from Australia, both reducing the power to ﬁnd
any, but the large effects in these sub-groups. Finally,
there were some differences in group composition
between those completing the survey by phone as
compared with online. We are not sure what these
differences mean. Older and lower SES respondents
were more likely to be surveyed by phone, but this does
not explain the differences found. We cannot think of
any way that the differential groupmembership by survey
mode we found could have led to any of the by-group
differences we found, but cannot rule them out.
It is important to note that we only studied
intentions, and they do not always translate into
behaviour. Longitudinal studies, or in this case
additional waves of this study, are needed to see to what
extent intentions are predictive of use. That said, all had
had some experience of use, so the responses can be
assumed to be grounded in at least some past
experience, albeit it is less clear for past users, as some
had no regular use and might have used less attractive
early generation devices.
In summary, the ﬁndings of this study indicate that
among those with at least some experience of vaping,
both current and former users, intentions around vaping
appear to be largely rational. The misperceptions that
exist around harms [23] may be inhibiting use.
Misbeliefs may also be leading to less quitting smoking
that would otherwise be the case. Evidence shows that
vaping is at least as effective as conventional nicotine
replacement therapy for smoking cessation [31,32] and
that it is much more acceptable to smokers [33] and
that newer products may be even more effective in
nicotine delivery [34,35] and satisfying. Further, given
the rated importance of satisfaction, it is likely that there
will be increased use of these products if levels of
satisfaction generated by these products increase.
Whether increased satisfaction and thus more extended
use lead to reduced relapse or just persistent
recreational use is unclear at this point. However, our
ﬁnding that ex-smoking past vapers saw preventing
relapse as a reason they might use in the future and that
only a minority intended to continue for recreational
reasons both suggest that the role of vaping in smoking
cessation is more important for most.
Conclusions
Factors inﬂuencing intentions to use PVs vary by
smoking and/or vaping status. The ﬁndings are generally
consistent with evidence from previous studies
suggesting that people evaluate whether to perform a
B. H. Ma et al.
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behaviour based on both the instrumental and
experiential components of the given behaviour [8] and
translate these beliefs into intentions in a largely rational
way. It remains unclear the extent towhich intentions will
translate into behaviour, which we acknowledge is also
strongly affected by affective reactions [9]. The likelihood
of intentions translating into action is also likely to be
affected by changes in the PV products and the nature
of the social context, including rules and emergent norms
aroundPVuse. However, based on the present levels, it is
unlikely that there will be a strong move towards vaping
among past users and most current vapers plan to stop.
If services decided to promote vaping to facilitate
smoking cessation, work would be needed to change the
minds of non-vapers to encourage them to try it as a
means of helping them quit. At present, there seems little
risk of a mass movement towards vaping.
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